EHI
TMDX icon

Eagle Health Investments’s Transmedics TMDX Stock Holding History

Eagle Health Investments’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,661
Closed -$6.77M – 24
2025
Q1 		$6.77M Buy
100,661
+82,600
+457% +$5.68M 1.76% 17
2024
Q4 		$1.13M Hold
18,061
– – 0.28% 17
2024
Q3 		$2.84M Sell
18,061
-114,800
-86% -$17.7M 0.54% 22
2024
Q2 		$20M Sell
132,861
-145,794
-52% -$17.5M 3.51% 12
2024
Q1 		$20.6M Sell
278,655
-36,200
-11% -$2.98M 3.83% 10
2023
Q4 		$24.9M Sell
314,855
-99,350
-24% -$5.99M 5.05% 10
2023
Q3 		$22.7M Buy
414,205
+182,173
+79% +$13.1M 5% 10
2023
Q2 		$19.5M Buy
+232,032
New +$17.8M 3.64% 15

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eagle Health Investments's TMDX Position: Q2 2025 in Review

Eagle Health Investments sold out of Transmedics (TMDX) in Q2 2025, closing a stake of 100,661 shares — an estimated $6.77M sold.

Eagle Health Investments first reported a position in TMDX in Q2 2023 and held it in 8 quarters. The position peaked at $24.9M in Q4 2023. 368 funds tracked by Wall St. Rank hold TMDX as of Q2 2025.

  • Eagle Health Investments reported no remaining Transmedics position as of Q2 2025 after selling out during the quarter.
  • Eagle Health Investments sold 100,661 Transmedics shares in Q2 2025, an estimated $6.77M.
  • Eagle Health Investments first reported a position in Transmedics in Q2 2023 and held it in 8 quarters.
  • Eagle Health Investments's Transmedics position peaked at $24.9M in Q4 2023.
  • 368 funds tracked by Wall St. Rank held Transmedics as of Q2 2025.

Based on Eagle Health Investments's 13F filing for Q2 2025, filed 12 Aug 2025.